Serum 5-S-Cysteinyl-Dopa Levels as a Predictive Marker for the Efficacy of Nivolumab in Advanced Malignant Melanoma

International Journal of Biological Markers - Italy
doi 10.1177/1724600819883658
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Serum Levels of S-Glutathionylated Proteins as a Risk-Marker for Arteriosclerosis Obliterans

Circulation Journal
MedicineCardiovascular MedicineCardiology
2007English

Evaluation of Serum 5-S - CD Value as Biochemical Markers of Malignant Melanoma ( Total 66 National Facilities : Midterm Report ).

Skin Cancer
1995English

Serum MMP-2 as a Potential Predictive Marker for Papillary Thyroid Carcinoma

PLoS ONE
Multidisciplinary
2018English

PET Scans as a Predictive Marker of Survival in Advanced Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2015English

Ipilimumab Combined With Nivolumab: A Standard of Care for the Treatment of Advanced Melanoma?

Clinical Cancer Research
Cancer ResearchOncology
2016English

An Update on the Safety of Nivolumab for the Treatment of Advanced Melanoma

Expert Opinion on Drug Safety
MedicinePharmacology
2020English

Pcn184 - Cost-Effectiveness of Nivolumab Plus Ipilimumab in Advanced Melanoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Serum Activin B Levels as Predictive Biomarker for Ectopic Pregnancy

Canadian Journal of Biotechnology
2017English

Elevated Serum Mannose Levels as a Marker of Polycystic Ovary Syndrome

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy